Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Identifieur interne : 002111 ( Ncbi/Merge ); précédent : 002110; suivant : 002112Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Auteurs : Yoshinobu Onuma [Pays-Bas] ; Patrick W. Serruys [Pays-Bas] ; Takashi Muramatsu [Pays-Bas] ; Shimpei Nakatani [Pays-Bas] ; Robert-Jan Van Geuns [Pays-Bas] ; Bernard De Bruyne [Belgique] ; Dariusz Dudek [Pologne] ; Evald Christiansen [Danemark] ; Pieter C. Smits [Pays-Bas] ; Bernard Chevalier [France] ; Dougal Mcclean [Nouvelle-Zélande] ; Jacques Koolen [Pays-Bas] ; Stephan Windecker [Suisse] ; Robert Whitbourn [Australie] ; Ian Meredith [Australie] ; Hector M. Garcia-Garcia [Pays-Bas] ; Susan Veldhof [Belgique] ; Richard Rapoza [États-Unis] ; John A. Ormiston [Nouvelle-Zélande]Source :
- JACC. Cardiovascular interventions [ 1876-7605 ] ; 2014.
Descripteurs français
- KwdFr :
- Agents cardiovasculaires (administration et posologie), Angioplastie coronaire par ballonnet (effets indésirables), Angioplastie coronaire par ballonnet (instrumentation), Conception de prothèse, Endoprothèses à élution de substances, Facteurs temps, Femelle, Humains, Implant résorbable, Maladie des artères coronaires (), Maladie des artères coronaires (diagnostic), Mâle, Résultat thérapeutique, Sirolimus (administration et posologie), Sirolimus (analogues et dérivés), Sujet âgé, Sujet âgé de 80 ans ou plus, Tomographie par cohérence optique, Vaisseaux coronaires (anatomopathologie), Valeur prédictive des tests, Évérolimus.
- MESH :
- administration et posologie : Agents cardiovasculaires, Sirolimus.
- analogues et dérivés : Sirolimus.
- anatomopathologie : Vaisseaux coronaires.
- diagnostic : Maladie des artères coronaires.
- effets indésirables : Angioplastie coronaire par ballonnet.
- instrumentation : Angioplastie coronaire par ballonnet, Conception de prothèse, Endoprothèses à élution de substances, Facteurs temps, Femelle, Humains, Implant résorbable, Maladie des artères coronaires, Mâle, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Tomographie par cohérence optique, Valeur prédictive des tests, Évérolimus.
English descriptors
- KwdEn :
- Absorbable Implants, Aged, Aged, 80 and over, Angioplasty, Balloon, Coronary (adverse effects), Angioplasty, Balloon, Coronary (instrumentation), Cardiovascular Agents (administration & dosage), Coronary Artery Disease (diagnosis), Coronary Artery Disease (therapy), Coronary Vessels (pathology), Drug-Eluting Stents, Everolimus, Female, Humans, Male, Predictive Value of Tests, Prosthesis Design, Sirolimus (administration & dosage), Sirolimus (analogs & derivatives), Time Factors, Tomography, Optical Coherence, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Cardiovascular Agents, Sirolimus.
- adverse effects : Angioplasty, Balloon, Coronary.
- chemical , analogs & derivatives : Sirolimus.
- diagnosis : Coronary Artery Disease.
- instrumentation : Angioplasty, Balloon, Coronary.
- pathology : Coronary Vessels.
- therapy : Coronary Artery Disease.
- Absorbable Implants, Aged, Aged, 80 and over, Drug-Eluting Stents, Everolimus, Female, Humans, Male, Predictive Value of Tests, Prosthesis Design, Time Factors, Tomography, Optical Coherence, Treatment Outcome.
Abstract
This study sought to describe the frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the second-generation Absorb bioresorbable polymeric vascular scaffolds (Absorb BVS, Abbott Vascular, Santa Clara, California) in the ABSORB (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) cohort B study by optical coherence tomography (OCT) post-procedure and at 6, 12, 24, and 36 months.
DOI: 10.1016/j.jcin.2014.06.016
PubMed: 25523532
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003243
- to stream PubMed, to step Curation: 003133
- to stream PubMed, to step Checkpoint: 003133
Links to Exploration step
pubmed:25523532Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).</title><author><name sortKey="Onuma, Yoshinobu" sort="Onuma, Yoshinobu" uniqKey="Onuma Y" first="Yoshinobu" last="Onuma">Yoshinobu Onuma</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: patrick.w.j.c.serruys@gmail.com.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Muramatsu, Takashi" sort="Muramatsu, Takashi" uniqKey="Muramatsu T" first="Takashi" last="Muramatsu">Takashi Muramatsu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Nakatani, Shimpei" sort="Nakatani, Shimpei" uniqKey="Nakatani S" first="Shimpei" last="Nakatani">Shimpei Nakatani</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Van Geuns, Robert Jan" sort="Van Geuns, Robert Jan" uniqKey="Van Geuns R" first="Robert-Jan" last="Van Geuns">Robert-Jan Van Geuns</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="De Bruyne, Bernard" sort="De Bruyne, Bernard" uniqKey="De Bruyne B" first="Bernard" last="De Bruyne">Bernard De Bruyne</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Cardiovascular Center, Aalst, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Interventional Cardiology, Cardiovascular Center, Aalst</wicri:regionArea><wicri:noRegion>Aalst</wicri:noRegion></affiliation></author><author><name sortKey="Dudek, Dariusz" sort="Dudek, Dariusz" uniqKey="Dudek D" first="Dariusz" last="Dudek">Dariusz Dudek</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology and Cardiovascular Interventions, Jagiellonian University, Krakow, Poland.</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Cardiology and Cardiovascular Interventions, Jagiellonian University, Krakow</wicri:regionArea><wicri:noRegion>Krakow</wicri:noRegion></affiliation></author><author><name sortKey="Christiansen, Evald" sort="Christiansen, Evald" uniqKey="Christiansen E" first="Evald" last="Christiansen">Evald Christiansen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Skejby Sygehus University Hospital, Aarhus, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Cardiology, Skejby Sygehus University Hospital, Aarhus</wicri:regionArea><wicri:noRegion>Aarhus</wicri:noRegion></affiliation></author><author><name sortKey="Smits, Pieter C" sort="Smits, Pieter C" uniqKey="Smits P" first="Pieter C" last="Smits">Pieter C. Smits</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, Maasstad Hospital, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name><affiliation wicri:level="1"><nlm:affiliation>Institut Cardiovasculaire Paris Sud, Institut Jacques Cartier, Massy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Cardiovasculaire Paris Sud, Institut Jacques Cartier, Massy</wicri:regionArea><wicri:noRegion>Massy</wicri:noRegion><wicri:noRegion>Massy</wicri:noRegion></affiliation></author><author><name sortKey="Mcclean, Dougal" sort="Mcclean, Dougal" uniqKey="Mcclean D" first="Dougal" last="Mcclean">Dougal Mcclean</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Christchurch Hospital, Christchurch, New Zealand.</nlm:affiliation><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Department of Interventional Cardiology, Christchurch Hospital, Christchurch</wicri:regionArea><wicri:noRegion>Christchurch</wicri:noRegion></affiliation></author><author><name sortKey="Koolen, Jacques" sort="Koolen, Jacques" uniqKey="Koolen J" first="Jacques" last="Koolen">Jacques Koolen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Catharina Hospital, Eindhoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, Catharina Hospital, Eindhoven</wicri:regionArea><wicri:noRegion>Eindhoven</wicri:noRegion></affiliation></author><author><name sortKey="Windecker, Stephan" sort="Windecker, Stephan" uniqKey="Windecker S" first="Stephan" last="Windecker">Stephan Windecker</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, Bern University Hospital, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Interventional Cardiology, Bern University Hospital, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName></affiliation></author><author><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name><affiliation wicri:level="1"><nlm:affiliation>Cardiac Investigation Unit, St. Vincents Hospital, Fitzroy, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Cardiac Investigation Unit, St. Vincents Hospital, Fitzroy</wicri:regionArea><wicri:noRegion>Fitzroy</wicri:noRegion></affiliation></author><author><name sortKey="Meredith, Ian" sort="Meredith, Ian" uniqKey="Meredith I" first="Ian" last="Meredith">Ian Meredith</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine, Cardiology, Monash Cardiovascular Research Centre, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Medicine, Cardiology, Monash Cardiovascular Research Centre, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Garcia Garcia, Hector M" sort="Garcia Garcia, Hector M" uniqKey="Garcia Garcia H" first="Hector M" last="Garcia-Garcia">Hector M. Garcia-Garcia</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, Cardialysis, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, Cardialysis, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Veldhof, Susan" sort="Veldhof, Susan" uniqKey="Veldhof S" first="Susan" last="Veldhof">Susan Veldhof</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Research, Abbott Vascular, Diegem, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Clinical Research, Abbott Vascular, Diegem</wicri:regionArea><wicri:noRegion>Diegem</wicri:noRegion></affiliation></author><author><name sortKey="Rapoza, Richard" sort="Rapoza, Richard" uniqKey="Rapoza R" first="Richard" last="Rapoza">Richard Rapoza</name><affiliation wicri:level="2"><nlm:affiliation>Research and Development, Abbott Vascular, Santa Clara, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Research and Development, Abbott Vascular, Santa Clara</wicri:cityArea></affiliation></author><author><name sortKey="Ormiston, John A" sort="Ormiston, John A" uniqKey="Ormiston J" first="John A" last="Ormiston">John A. Ormiston</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Auckland City Hospital, Auckland, New Zealand.</nlm:affiliation><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Department of Interventional Cardiology, Auckland City Hospital, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25523532</idno><idno type="pmid">25523532</idno><idno type="doi">10.1016/j.jcin.2014.06.016</idno><idno type="wicri:Area/PubMed/Corpus">003243</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003243</idno><idno type="wicri:Area/PubMed/Curation">003133</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003133</idno><idno type="wicri:Area/PubMed/Checkpoint">003133</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003133</idno><idno type="wicri:Area/Ncbi/Merge">002111</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).</title><author><name sortKey="Onuma, Yoshinobu" sort="Onuma, Yoshinobu" uniqKey="Onuma Y" first="Yoshinobu" last="Onuma">Yoshinobu Onuma</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: patrick.w.j.c.serruys@gmail.com.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Muramatsu, Takashi" sort="Muramatsu, Takashi" uniqKey="Muramatsu T" first="Takashi" last="Muramatsu">Takashi Muramatsu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Nakatani, Shimpei" sort="Nakatani, Shimpei" uniqKey="Nakatani S" first="Shimpei" last="Nakatani">Shimpei Nakatani</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Van Geuns, Robert Jan" sort="Van Geuns, Robert Jan" uniqKey="Van Geuns R" first="Robert-Jan" last="Van Geuns">Robert-Jan Van Geuns</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="De Bruyne, Bernard" sort="De Bruyne, Bernard" uniqKey="De Bruyne B" first="Bernard" last="De Bruyne">Bernard De Bruyne</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Cardiovascular Center, Aalst, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Interventional Cardiology, Cardiovascular Center, Aalst</wicri:regionArea><wicri:noRegion>Aalst</wicri:noRegion></affiliation></author><author><name sortKey="Dudek, Dariusz" sort="Dudek, Dariusz" uniqKey="Dudek D" first="Dariusz" last="Dudek">Dariusz Dudek</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology and Cardiovascular Interventions, Jagiellonian University, Krakow, Poland.</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Cardiology and Cardiovascular Interventions, Jagiellonian University, Krakow</wicri:regionArea><wicri:noRegion>Krakow</wicri:noRegion></affiliation></author><author><name sortKey="Christiansen, Evald" sort="Christiansen, Evald" uniqKey="Christiansen E" first="Evald" last="Christiansen">Evald Christiansen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Skejby Sygehus University Hospital, Aarhus, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Cardiology, Skejby Sygehus University Hospital, Aarhus</wicri:regionArea><wicri:noRegion>Aarhus</wicri:noRegion></affiliation></author><author><name sortKey="Smits, Pieter C" sort="Smits, Pieter C" uniqKey="Smits P" first="Pieter C" last="Smits">Pieter C. Smits</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, Maasstad Hospital, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name><affiliation wicri:level="1"><nlm:affiliation>Institut Cardiovasculaire Paris Sud, Institut Jacques Cartier, Massy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Cardiovasculaire Paris Sud, Institut Jacques Cartier, Massy</wicri:regionArea><wicri:noRegion>Massy</wicri:noRegion><wicri:noRegion>Massy</wicri:noRegion></affiliation></author><author><name sortKey="Mcclean, Dougal" sort="Mcclean, Dougal" uniqKey="Mcclean D" first="Dougal" last="Mcclean">Dougal Mcclean</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Christchurch Hospital, Christchurch, New Zealand.</nlm:affiliation><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Department of Interventional Cardiology, Christchurch Hospital, Christchurch</wicri:regionArea><wicri:noRegion>Christchurch</wicri:noRegion></affiliation></author><author><name sortKey="Koolen, Jacques" sort="Koolen, Jacques" uniqKey="Koolen J" first="Jacques" last="Koolen">Jacques Koolen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Catharina Hospital, Eindhoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, Catharina Hospital, Eindhoven</wicri:regionArea><wicri:noRegion>Eindhoven</wicri:noRegion></affiliation></author><author><name sortKey="Windecker, Stephan" sort="Windecker, Stephan" uniqKey="Windecker S" first="Stephan" last="Windecker">Stephan Windecker</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, Bern University Hospital, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Interventional Cardiology, Bern University Hospital, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName></affiliation></author><author><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name><affiliation wicri:level="1"><nlm:affiliation>Cardiac Investigation Unit, St. Vincents Hospital, Fitzroy, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Cardiac Investigation Unit, St. Vincents Hospital, Fitzroy</wicri:regionArea><wicri:noRegion>Fitzroy</wicri:noRegion></affiliation></author><author><name sortKey="Meredith, Ian" sort="Meredith, Ian" uniqKey="Meredith I" first="Ian" last="Meredith">Ian Meredith</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine, Cardiology, Monash Cardiovascular Research Centre, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Medicine, Cardiology, Monash Cardiovascular Research Centre, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Garcia Garcia, Hector M" sort="Garcia Garcia, Hector M" uniqKey="Garcia Garcia H" first="Hector M" last="Garcia-Garcia">Hector M. Garcia-Garcia</name><affiliation wicri:level="3"><nlm:affiliation>Department of Interventional Cardiology, Cardialysis, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Interventional Cardiology, Cardialysis, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Veldhof, Susan" sort="Veldhof, Susan" uniqKey="Veldhof S" first="Susan" last="Veldhof">Susan Veldhof</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Research, Abbott Vascular, Diegem, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Clinical Research, Abbott Vascular, Diegem</wicri:regionArea><wicri:noRegion>Diegem</wicri:noRegion></affiliation></author><author><name sortKey="Rapoza, Richard" sort="Rapoza, Richard" uniqKey="Rapoza R" first="Richard" last="Rapoza">Richard Rapoza</name><affiliation wicri:level="2"><nlm:affiliation>Research and Development, Abbott Vascular, Santa Clara, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Research and Development, Abbott Vascular, Santa Clara</wicri:cityArea></affiliation></author><author><name sortKey="Ormiston, John A" sort="Ormiston, John A" uniqKey="Ormiston J" first="John A" last="Ormiston">John A. Ormiston</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Auckland City Hospital, Auckland, New Zealand.</nlm:affiliation><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Department of Interventional Cardiology, Auckland City Hospital, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author></analytic><series><title level="j">JACC. Cardiovascular interventions</title><idno type="eISSN">1876-7605</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorbable Implants</term><term>Aged</term><term>Aged, 80 and over</term><term>Angioplasty, Balloon, Coronary (adverse effects)</term><term>Angioplasty, Balloon, Coronary (instrumentation)</term><term>Cardiovascular Agents (administration & dosage)</term><term>Coronary Artery Disease (diagnosis)</term><term>Coronary Artery Disease (therapy)</term><term>Coronary Vessels (pathology)</term><term>Drug-Eluting Stents</term><term>Everolimus</term><term>Female</term><term>Humans</term><term>Male</term><term>Predictive Value of Tests</term><term>Prosthesis Design</term><term>Sirolimus (administration & dosage)</term><term>Sirolimus (analogs & derivatives)</term><term>Time Factors</term><term>Tomography, Optical Coherence</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents cardiovasculaires (administration et posologie)</term><term>Angioplastie coronaire par ballonnet (effets indésirables)</term><term>Angioplastie coronaire par ballonnet (instrumentation)</term><term>Conception de prothèse</term><term>Endoprothèses à élution de substances</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Implant résorbable</term><term>Maladie des artères coronaires ()</term><term>Maladie des artères coronaires (diagnostic)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sirolimus (administration et posologie)</term><term>Sirolimus (analogues et dérivés)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tomographie par cohérence optique</term><term>Vaisseaux coronaires (anatomopathologie)</term><term>Valeur prédictive des tests</term><term>Évérolimus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cardiovascular Agents</term><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents cardiovasculaires</term><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Angioplasty, Balloon, Coronary</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Vaisseaux coronaires</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronary Artery Disease</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladie des artères coronaires</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Angioplastie coronaire par ballonnet</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Angioplasty, Balloon, Coronary</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronary Vessels</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronary Artery Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Absorbable Implants</term><term>Aged</term><term>Aged, 80 and over</term><term>Drug-Eluting Stents</term><term>Everolimus</term><term>Female</term><term>Humans</term><term>Male</term><term>Predictive Value of Tests</term><term>Prosthesis Design</term><term>Time Factors</term><term>Tomography, Optical Coherence</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="fr"><term>Angioplastie coronaire par ballonnet</term><term>Conception de prothèse</term><term>Endoprothèses à élution de substances</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Implant résorbable</term><term>Maladie des artères coronaires</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tomographie par cohérence optique</term><term>Valeur prédictive des tests</term><term>Évérolimus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study sought to describe the frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the second-generation Absorb bioresorbable polymeric vascular scaffolds (Absorb BVS, Abbott Vascular, Santa Clara, California) in the ABSORB (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) cohort B study by optical coherence tomography (OCT) post-procedure and at 6, 12, 24, and 36 months.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25523532</PMID><DateCreated><Year>2014</Year><Month>12</Month><Day>19</Day></DateCreated><DateCompleted><Year>2015</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1876-7605</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>JACC. Cardiovascular interventions</Title><ISOAbbreviation>JACC Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).</ArticleTitle><Pagination><MedlinePgn>1400-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcin.2014.06.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1936-8798(14)01357-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to describe the frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the second-generation Absorb bioresorbable polymeric vascular scaffolds (Absorb BVS, Abbott Vascular, Santa Clara, California) in the ABSORB (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) cohort B study by optical coherence tomography (OCT) post-procedure and at 6, 12, 24, and 36 months.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fully bioresorbable scaffolds are a novel approach to treatment for coronary narrowing that provides transient vessel support with drug delivery capability without the long-term limitations of metallic drug-eluting stents. However, a potential drawback of the bioresorbable scaffold is the potential for disruption of the strut network when overexpanded. Conversely, the structural discontinuity of the polymeric struts at a late stage is a biologically programmed fate of the scaffold during the course of bioresorption.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The ABSORB cohort B trial is a multicenter single-arm trial assessing the safety and performance of the Absorb BVS in the treatment of 101 patients with de novo native coronary artery lesions. The current analysis included 51 patients with 143 OCT pullbacks who underwent OCT at baseline and follow-up. The presence of acute disruption or late discontinuities was diagnosed by the presence on OCT of stacked, overhung struts or isolated intraluminal struts disconnected from the expected circularity of the device.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 51 patients with OCT imaging post-procedure, acute scaffold disruption was observed in 2 patients (3.9%), which could be related to overexpansion of the scaffold at the time of implantation. One patient had a target lesion revascularization that was presumably related to the disruption. Of 49 patients without acute disruption, late discontinuities were observed in 21 patients. There were no major adverse cardiac events associated with this finding except for 1 patient who had a non-ischemia-driven target lesion revascularization.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Acute scaffold disruption is a rare iatrogenic phenomenon that has been anecdotally associated with anginal symptoms, whereas late strut discontinuity is observed in approximately 40% of patients and could be viewed as a serendipitous OCT finding of a normal bioresorption process without clinical implications. (ABSORB Clinical Investigation, Cohort B [ABSORB B]; NCT00856856).</AbstractText><CopyrightInformation>Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Onuma</LastName><ForeName>Yoshinobu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serruys</LastName><ForeName>Patrick W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: patrick.w.j.c.serruys@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muramatsu</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakatani</LastName><ForeName>Shimpei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Geuns</LastName><ForeName>Robert-Jan</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bruyne</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Cardiovascular Center, Aalst, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudek</LastName><ForeName>Dariusz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Interventions, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiansen</LastName><ForeName>Evald</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Skejby Sygehus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smits</LastName><ForeName>Pieter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institut Cardiovasculaire Paris Sud, Institut Jacques Cartier, Massy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClean</LastName><ForeName>Dougal</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Christchurch Hospital, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koolen</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Catharina Hospital, Eindhoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Windecker</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Bern University Hospital, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitbourn</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiac Investigation Unit, St. Vincents Hospital, Fitzroy, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meredith</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cardiology, Monash Cardiovascular Research Centre, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Garcia</LastName><ForeName>Hector M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Cardialysis, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldhof</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Abbott Vascular, Diegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapoza</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research and Development, Abbott Vascular, Santa Clara, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ormiston</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Auckland City Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00856856</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Cardiovasc Interv</MedlineTA><NlmUniqueID>101467004</NlmUniqueID><ISSNLinking>1936-8798</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002317">Cardiovascular Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9HW64Q8G6G</RegistryNumber><NameOfSubstance UI="D000068338">Everolimus</NameOfSubstance></Chemical><Chemical><RegistryNumber>W36ZG6FT64</RegistryNumber><NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020341" MajorTopicYN="Y">Absorbable Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015906" MajorTopicYN="N">Angioplasty, Balloon, Coronary</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002317" MajorTopicYN="N">Cardiovascular Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="N">Coronary Vessels</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054855" MajorTopicYN="Y">Drug-Eluting Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068338" MajorTopicYN="N">Everolimus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="Y">Tomography, Optical Coherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atherosclerosis</Keyword><Keyword MajorTopicYN="N">biodegradable polymer</Keyword><Keyword MajorTopicYN="N">bioresorbable scaffold</Keyword><Keyword MajorTopicYN="N">everolimus</Keyword><Keyword MajorTopicYN="N">stent</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25523532</ArticleId><ArticleId IdType="pii">S1936-8798(14)01357-0</ArticleId><ArticleId IdType="doi">10.1016/j.jcin.2014.06.016</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>Danemark</li><li>France</li><li>Nouvelle-Zélande</li><li>Pays-Bas</li><li>Pologne</li><li>Suisse</li><li>États-Unis</li></country><region><li>Californie</li><li>Canton de Berne</li><li>Hollande-Méridionale</li><li>Victoria (État)</li></region><settlement><li>Berne</li><li>Melbourne</li><li>Rotterdam</li></settlement></list><tree><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Onuma, Yoshinobu" sort="Onuma, Yoshinobu" uniqKey="Onuma Y" first="Yoshinobu" last="Onuma">Yoshinobu Onuma</name></region><name sortKey="Garcia Garcia, Hector M" sort="Garcia Garcia, Hector M" uniqKey="Garcia Garcia H" first="Hector M" last="Garcia-Garcia">Hector M. Garcia-Garcia</name><name sortKey="Koolen, Jacques" sort="Koolen, Jacques" uniqKey="Koolen J" first="Jacques" last="Koolen">Jacques Koolen</name><name sortKey="Muramatsu, Takashi" sort="Muramatsu, Takashi" uniqKey="Muramatsu T" first="Takashi" last="Muramatsu">Takashi Muramatsu</name><name sortKey="Nakatani, Shimpei" sort="Nakatani, Shimpei" uniqKey="Nakatani S" first="Shimpei" last="Nakatani">Shimpei Nakatani</name><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><name sortKey="Smits, Pieter C" sort="Smits, Pieter C" uniqKey="Smits P" first="Pieter C" last="Smits">Pieter C. Smits</name><name sortKey="Van Geuns, Robert Jan" sort="Van Geuns, Robert Jan" uniqKey="Van Geuns R" first="Robert-Jan" last="Van Geuns">Robert-Jan Van Geuns</name></country><country name="Belgique"><noRegion><name sortKey="De Bruyne, Bernard" sort="De Bruyne, Bernard" uniqKey="De Bruyne B" first="Bernard" last="De Bruyne">Bernard De Bruyne</name></noRegion><name sortKey="Veldhof, Susan" sort="Veldhof, Susan" uniqKey="Veldhof S" first="Susan" last="Veldhof">Susan Veldhof</name></country><country name="Pologne"><noRegion><name sortKey="Dudek, Dariusz" sort="Dudek, Dariusz" uniqKey="Dudek D" first="Dariusz" last="Dudek">Dariusz Dudek</name></noRegion></country><country name="Danemark"><noRegion><name sortKey="Christiansen, Evald" sort="Christiansen, Evald" uniqKey="Christiansen E" first="Evald" last="Christiansen">Evald Christiansen</name></noRegion></country><country name="France"><noRegion><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name></noRegion></country><country name="Nouvelle-Zélande"><noRegion><name sortKey="Mcclean, Dougal" sort="Mcclean, Dougal" uniqKey="Mcclean D" first="Dougal" last="Mcclean">Dougal Mcclean</name></noRegion><name sortKey="Ormiston, John A" sort="Ormiston, John A" uniqKey="Ormiston J" first="John A" last="Ormiston">John A. Ormiston</name></country><country name="Suisse"><region name="Canton de Berne"><name sortKey="Windecker, Stephan" sort="Windecker, Stephan" uniqKey="Windecker S" first="Stephan" last="Windecker">Stephan Windecker</name></region></country><country name="Australie"><noRegion><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name></noRegion><name sortKey="Meredith, Ian" sort="Meredith, Ian" uniqKey="Meredith I" first="Ian" last="Meredith">Ian Meredith</name></country><country name="États-Unis"><region name="Californie"><name sortKey="Rapoza, Richard" sort="Rapoza, Richard" uniqKey="Rapoza R" first="Richard" last="Rapoza">Richard Rapoza</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002111 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002111 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:25523532
|texte= Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25523532" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |